Job cuts at Biogen, which has big RTP presence, help drug giant reduce costs 40%
Cost cutting helped Biogen beat second-quarter expectations soundly even as revenue slid and sales of the drugmaker’s controversial Alzheimer’s treatment collapsed.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
